Low Choline Concentrations in Normal-Appearing White Matter of Patients with Multiple Sclerosis and Normal MR Imaging Brain Scans

References

1. ↵
   Compston A, Coles A. Multiple sclerosis. Lancet 2002;359:1221–31

   CrossRefPubMedWeb of Science
2. ↵
   Kapeller P, McLean MA, Griffin CM, et al. Preliminary evidence for neuronal damage in cortical grey matter and normal appearing white matter in short duration relapsing-remitting multiple sclerosis: a quantitative MR spectroscopic imaging study. J Neurol 2001;248:131–38

   CrossRefPubMedWeb of Science
3. ↵
   McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001;50:121–27

   CrossRefPubMedWeb of Science
4. ↵
   Larsson HB. Magnetic resonance imaging and spectroscopy. Acta Neurol Scand 1995;91:(suppl 159):36
5. ↵
   Filippi M, Grossman RI. MRI techniques to monitor MS evolution: the present and the future. Neurology 2002;58:1147–53

   Abstract/FREE Full Text
6. ↵
   Chard DT, Griffin CM, McLean MA, et al. Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis. Brain 2002;125:2342–52

   Abstract/FREE Full Text
7. ↵
   Brenner RE, Munro PM, Williams SC, et al. The proton NMR spectrum in acute EAE: the significance of the change in the Cho:Cr ratio. Magn Reson Med 1993;29:737–45

   PubMedWeb of Science
8. ↵
   Rovira A, Pericot I, Alonso J, et al. Serial diffusion-weighted MR imaging and proton MR spectroscopy of acute large demyelinating brain lesions: case report. AJNR Am J Neuroradiol 2002;23:989–94

   Abstract/FREE Full Text
9. ↵
   Bitsch A, Bruhn H, Vougioukas V, et al. Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy. AJNR Am J Neuroradiol 1999;20:1619–27

   Abstract/FREE Full Text
10. ↵
    Helms G, Stawiarz L, Kivisakk P, et al. Regression analysis of metabolite concentrations estimated from localized proton MR spectra of active and chronic multiple sclerosis lesions. Magn Reson Med 2000;43:102–10

    CrossRefPubMedWeb of Science
11. ↵
    Tourbah A, Stievenart JL, Abanou A, et al. Normal-appearing white matter in optic neuritis and multiple sclerosis: a comparative proton spectroscopy study. Neuroradiology 1999;41:738–43

    CrossRefPubMedWeb of Science
12. ↵
    Tartaglia MC, Narayanan S, De Stefano N, et al. Choline is increased in pre-lesional normal appearing white matter in multiple sclerosis. J Neurol 2002;249:1382–90

    CrossRefPubMedWeb of Science
13. ↵
    Whittall KP, MacKay AL, Li DK, et al. Normal-appearing white matter in multiple sclerosis has heterogeneous, diffusely prolonged T(2). Magn Reson Med 2002;47:403–08

    CrossRefPubMedWeb of Science
14. ↵
    Davies SE, Newcombe J, Williams SR, et al. High resolution proton NMR spectroscopy of multiple sclerosis lesions. J Neurochem 1995;64:742–48

    PubMedWeb of Science
15. ↵
    Inglese M, Li BS, Rusinek H, et al. Diffusely elevated cerebral choline and creatine in relapsing-remitting multiple sclerosis. Magn Reson Med 2003;50:190–95

    CrossRefPubMedWeb of Science
16. ↵
    Filippi M, Rocca MA, Minicucci L, et al. Magnetization transfer imaging of patients with definite MS and negative conventional MRI. Neurology 1999;52:845–48

    Abstract/FREE Full Text
17. ↵
    Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227–31

    CrossRefPubMedWeb of Science
18. ↵
    Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444–52

    Abstract/FREE Full Text
19. ↵
    Helms G. A precise and user-independent quantification technique for regional comparison of single volume proton MR spectroscopy of the human brain. NMR Biomed 2000;13:398–406

    CrossRefPubMed
20. ↵
    Klose U. In vivo proton spectroscopy in presence of eddy currents. Magn Reson Med 1990;14:26

    PubMedWeb of Science
21. ↵
    Whittall KP, MacKay AL, Graeb DA, et al. In vivo measurements of T2 distributions and water contents in normal human brain. Magn Reson Med 1997;37:34–43

    CrossRefPubMedWeb of Science
22. ↵
    Frahm J, Bruhn H, Gyngell ML, et al. Localized proton NMR spectroscopy in different regions of the human brain in vivo. Relaxation times and concentrations of cerebral metabolites. Magn Reson Med 1989;11:47–63

    PubMed
23. ↵
    Brief EE, Whittall KP, Li DK, et al. Proton T1 relaxation times of cerebral metabolites differ within and between regions of normal human brain. NMR Biomed 2003;16:503–09

    CrossRefPubMed
24. ↵
    Pouwels PJ, Frahm J. Differential distribution of NAA and NAAG in human brain as determined by quantitative localized proton MRS. NMR Biomed 1997;10:73–78

    CrossRefPubMedWeb of Science
25. ↵
    Pouwels PJ, Frahm J. Regional metabolite concentrations in human brain as determined by quantitative localized proton MRS. Magn Reson Med 1998;39:53–60

    PubMedWeb of Science
26. ↵
    Thorpe JW, Kidd D, Moseley IF, et al. Spinal MRI in patients with suspected multiple sclerosis and negative brain MRI. Brain 1996;119:709–14

    Abstract/FREE Full Text
27. ↵
    Richards TL, Alvord EC Jr, He Y, et al. Experimental allergic encephalomyelitis in non-human primates: diffusion imaging of acute and chronic brain lesions. Mult Scler 1995;1:109–17

    Abstract/FREE Full Text
28. ↵
    Sarchielli P, Presciutti O, Pelliccioli GP, et al. Absolute quantification of brain metabolites by proton magnetic resonance spectroscopy in normal-appearing white matter of multiple sclerosis patients. Brain 1999;122:513–21

    Abstract/FREE Full Text
29. ↵
    Leary SM, Brex PA, MacManus DG, et al. A (1)H magnetic resonance spectroscopy study of aging in parietal white matter: implications for trials in multiple sclerosis. Magn Reson Imaging 2000;18:455–59

    CrossRefPubMedWeb of Science
30. ↵
    Bluml S, Seymour KJ, Ross BD. Developmental changes in choline- and ethanolamine-containing compounds measured with proton-decoupled (31)P MRS in in vivo human brain. Magn Reson Med 1999;42:643–54

    CrossRefPubMedWeb of Science
31. ↵
    Danielsen ER, Ross B. Magnetic Resonance Spectroscopy Diagnosis of Neurological Disease. New York, NY: Marcel Dekker;1998
32. ↵
    Zeisel SH. Choline: an essential nutrient for humans. Nutrition 2000;16:669–71

    CrossRefPubMedWeb of Science
33. ↵
    Bjartmar C, Kinkel RP, Kidd G, et al. Axonal loss in normal-appearing white matter in a patient with acute MS. Neurology 2001;57:1248–52

    Abstract/FREE Full Text
34. ↵
    Evangelou N, Esiri MM, Smith S, et al. Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis. Ann Neurol 2000;47:391–95

    CrossRefPubMedWeb of Science
35. ↵
    Kapeller P, Brex PA, Chard D, et al. Quantitative 1H MRS imaging 14 years after presenting with a clinically isolated syndrome suggestive of multiple sclerosis. Mult Scler 2002;8:207–10

    Abstract/FREE Full Text